{"id":61040,"date":"2025-04-04T01:02:42","date_gmt":"2025-04-03T23:02:42","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ardent-health-appoints-robert-demichiei-to-board-of-directors\/"},"modified":"2025-04-04T01:02:42","modified_gmt":"2025-04-03T23:02:42","slug":"ardent-health-appoints-robert-demichiei-to-board-of-directors","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ardent-health-appoints-robert-demichiei-to-board-of-directors\/","title":{"rendered":"Ardent Health Appoints Robert DeMichiei to Board of Directors"},"content":{"rendered":"
\n

BRENTWOOD, Tenn.–(BUSINESS WIRE)–Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nA seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC’s financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements.\n<\/p>\n

\nPrior to joining UPMC, Mr. DeMichiei held various executive roles with the General Electric Company and PricewaterhouseCoopers. He is a graduate of the University of Pittsburgh.\n<\/p>\n

\n“We are pleased to welcome Rob to our board of directors,” said Marty Bonick, Ardent Health president and CEO. “His deep understanding of healthcare finance and operations and extensive board experience will be instrumental in guiding Ardent\u2019s continued growth and focus on operational excellence.\u201d\n<\/p>\n

\nMr. DeMichiei also serves on the boards of several organizations, including Waystar Holding Corp. (Nasdaq: WAY), Ampco-Pittsburgh Corporation (NYSE: AP), and Auto Club Enterprises\/AAA, and is a strategic advisor to Health Catalyst (Nasdaq: HCAT) and Omega Healthcare Management Services. He will serve on the board\u2019s Audit & Compliance Committee and the Nominating & Corporate Governance Committee.\n<\/p>\n

\n“Rob\u2019s governance experience with publicly traded companies brings valuable insight and perspective,\u201d said Mark Sotir, chairman of the Ardent Health board. \u201cHis background \u2013 along with his leadership of one of the nation\u2019s preeminent academic health systems \u2013 will be a tremendous asset as we continue strengthening our board and advancing Ardent\u2019s long-term strategy.”\n<\/p>\n

\nAbout Ardent Health<\/b>\n<\/p>\n

\nArdent Health (NYSE: ARDT) is a leading provider of healthcare in growing mid-sized urban communities across the U.S. With a focus on people and investments in innovative services and technologies, Ardent is passionate about making healthcare better and easier to access. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and 280 sites of care with over 1,800 affiliated providers across six states. For more information, please visit ardenthealth.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact:<\/b>
Dave Styblo
\n
Investor.Relations@ardenthealth.com<\/a>
(615) 296-3016\n<\/p>\n

\nMedia Contact:<\/b>
Rebecca Kirkham
\n
Rebecca.Kirkham@ardenthealth.com<\/a>
(615) 296-3635\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BRENTWOOD, Tenn.–(BUSINESS WIRE)–Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61040","6":"format-standard","7":"category-industry"},"yoast_head":"\nArdent Health Appoints Robert DeMichiei to Board of Directors - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ardent-health-appoints-robert-demichiei-to-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ardent Health Appoints Robert DeMichiei to Board of Directors - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BRENTWOOD, Tenn.–(BUSINESS WIRE)–Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ardent-health-appoints-robert-demichiei-to-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-03T23:02:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250403944600\/en\/2089367\/22\/AH24_2000w.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ardent-health-appoints-robert-demichiei-to-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ardent-health-appoints-robert-demichiei-to-board-of-directors\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Ardent Health Appoints Robert DeMichiei to Board of Directors\",\"datePublished\":\"2025-04-03T23:02:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ardent-health-appoints-robert-demichiei-to-board-of-directors\\\/\"},\"wordCount\":392,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ardent-health-appoints-robert-demichiei-to-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250403944600\\\/en\\\/2089367\\\/22\\\/AH24_2000w.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ardent-health-appoints-robert-demichiei-to-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ardent-health-appoints-robert-demichiei-to-board-of-directors\\\/\",\"name\":\"Ardent Health Appoints Robert DeMichiei to Board of Directors - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ardent-health-appoints-robert-demichiei-to-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ardent-health-appoints-robert-demichiei-to-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250403944600\\\/en\\\/2089367\\\/22\\\/AH24_2000w.jpg\",\"datePublished\":\"2025-04-03T23:02:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ardent-health-appoints-robert-demichiei-to-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ardent-health-appoints-robert-demichiei-to-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ardent-health-appoints-robert-demichiei-to-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250403944600\\\/en\\\/2089367\\\/22\\\/AH24_2000w.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250403944600\\\/en\\\/2089367\\\/22\\\/AH24_2000w.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ardent-health-appoints-robert-demichiei-to-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ardent Health Appoints Robert DeMichiei to Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ardent Health Appoints Robert DeMichiei to Board of Directors - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ardent-health-appoints-robert-demichiei-to-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Ardent Health Appoints Robert DeMichiei to Board of Directors - Pharma Trend","og_description":"BRENTWOOD, Tenn.–(BUSINESS WIRE)–Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ardent-health-appoints-robert-demichiei-to-board-of-directors\/","og_site_name":"Pharma Trend","article_published_time":"2025-04-03T23:02:42+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250403944600\/en\/2089367\/22\/AH24_2000w.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ardent-health-appoints-robert-demichiei-to-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ardent-health-appoints-robert-demichiei-to-board-of-directors\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Ardent Health Appoints Robert DeMichiei to Board of Directors","datePublished":"2025-04-03T23:02:42+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ardent-health-appoints-robert-demichiei-to-board-of-directors\/"},"wordCount":392,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ardent-health-appoints-robert-demichiei-to-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250403944600\/en\/2089367\/22\/AH24_2000w.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ardent-health-appoints-robert-demichiei-to-board-of-directors\/","url":"https:\/\/pharma-trend.com\/en\/ardent-health-appoints-robert-demichiei-to-board-of-directors\/","name":"Ardent Health Appoints Robert DeMichiei to Board of Directors - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ardent-health-appoints-robert-demichiei-to-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ardent-health-appoints-robert-demichiei-to-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250403944600\/en\/2089367\/22\/AH24_2000w.jpg","datePublished":"2025-04-03T23:02:42+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ardent-health-appoints-robert-demichiei-to-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ardent-health-appoints-robert-demichiei-to-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ardent-health-appoints-robert-demichiei-to-board-of-directors\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250403944600\/en\/2089367\/22\/AH24_2000w.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250403944600\/en\/2089367\/22\/AH24_2000w.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ardent-health-appoints-robert-demichiei-to-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Ardent Health Appoints Robert DeMichiei to Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61040","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61040"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61040\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61040"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61040"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}